KPCB_RAT - dbPTM
KPCB_RAT - PTM Information in dbPTM
Basic Information of Protein
UniProt ID KPCB_RAT
UniProt AC P68403
Protein Name Protein kinase C beta type
Gene Name Prkcb
Organism Rattus norvegicus (Rat).
Sequence Length 671
Subcellular Localization Cytoplasm. Nucleus. Membrane
Peripheral membrane protein.
Protein Description Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-652'. Phosphorylation induces CARD11/CARMA1 association with lipid rafts and recruitment of the BCL10-MALT1 complex as well as MAP3K7/TAK1, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. Plays a direct role in the negative feedback regulation of the BCR signaling, by down-modulating BTK function via direct phosphorylation of BTK at 'Ser-180', which results in the alteration of BTK plasma membrane localization and in turn inhibition of BTK activity. Involved in apoptosis following oxidative damage: in case of oxidative conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to mitochondrial accumulation of p66Shc, where p66Shc acts as a reactive oxygen species producer. Acts as a coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag for epigenetic transcriptional activation that prevents demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A. In insulin signaling, may function downstream of IRS1 in muscle cells and mediate insulin-dependent DNA synthesis through the RAF1-MAPK/ERK signaling cascade. May participate in the regulation of glucose transport in adipocytes by negatively modulating the insulin-stimulated translocation of the glucose transporter SLC2A4/GLUT4. Under high glucose in pancreatic beta-cells, is probably involved in the inhibition of the insulin gene transcription, via regulation of MYC expression. In endothelial cells, activation of PRKCB induces increased phosphorylation of RB1, increased VEGFA-induced cell proliferation, and inhibits PI3K/AKT-dependent nitric oxide synthase (NOS3/eNOS) regulation by insulin, which causes endothelial dysfunction. Also involved in triglyceride homeostasis (By similarity). Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription..
Protein Sequence MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPASDDPRSKHKFKIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKARDKRDTSNFDKEFTRQPVELTPTDKLFIMNLDQNEFAGFSYTNPEFVINV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MADPAAGPP
------CCCCCCCCC
31.34-
11PhosphorylationPAAGPPPSEGEESTV
CCCCCCCCCCCHHHH
65.1027097102
16PhosphorylationPPSEGEESTVRFARK
CCCCCCHHHHHHHHH
28.098327493
17PhosphorylationPSEGEESTVRFARKG
CCCCCHHHHHHHHHH
20.988327493
38AcetylationVHEVKNHKFTARFFK
HHHHHCCCEEHHHHC
54.5322902405
48PhosphorylationARFFKQPTFCSHCTD
HHHHCCCCCCCHHHH
34.4823984901
51PhosphorylationFKQPTFCSHCTDFIW
HCCCCCCCHHHHCHH
19.8723984901
54PhosphorylationPTFCSHCTDFIWGFG
CCCCCHHHHCHHCCC
28.6423984901
108PhosphorylationKHKFKIHTYSSPTFC
CCEEEEEECCCCCCH
28.6827097102
109PhosphorylationHKFKIHTYSSPTFCD
CEEEEEECCCCCCHH
7.9327097102
110PhosphorylationKFKIHTYSSPTFCDH
EEEEEECCCCCCHHH
30.8827097102
111PhosphorylationFKIHTYSSPTFCDHC
EEEEECCCCCCHHHH
19.9727097102
113PhosphorylationIHTYSSPTFCDHCGS
EEECCCCCCHHHHHH
38.5527097102
120PhosphorylationTFCDHCGSLLYGLIH
CCHHHHHHHHHHHHH
22.1627097102
123PhosphorylationDHCGSLLYGLIHQGM
HHHHHHHHHHHHCCC
18.3827097102
192PhosphorylationPMDPNGLSDPYVKLK
CCCCCCCCCCCEEEE
37.63-
195PhosphorylationPNGLSDPYVKLKLIP
CCCCCCCCEEEEECC
18.40-
205AcetylationLKLIPDPKSESKQKT
EEECCCCCCCCCCCC
74.3922902405
206PhosphorylationKLIPDPKSESKQKTK
EECCCCCCCCCCCCC
53.1125403869
241PhosphorylationSDKDRRLSVEIWDWD
CCCCCCEEEEEEECC
18.85-
250PhosphorylationEIWDWDLTSRNDFMG
EEEECCCCCCCCHHH
24.14-
279PhosphorylationDGWFKLLSQEEGEYF
CHHHHHCCCCCCCCC
46.08-
285PhosphorylationLSQEEGEYFNVPVPP
CCCCCCCCCCCCCCC
16.00-
295PhosphorylationVPVPPEGSEGNEELR
CCCCCCCCCCCHHHH
40.44-
314PhosphorylationRAKIGQGTKAPEEKT
HHHCCCCCCCCCHHC
19.028327493
320UbiquitinationGTKAPEEKTANTISK
CCCCCCHHCCCCHHC
51.80-
324PhosphorylationPEEKTANTISKFDNN
CCHHCCCCHHCCCCC
24.948327493
352PhosphorylationLMVLGKGSFGKVMLS
EEEECCCCCCHHEEC
34.0223984901
362UbiquitinationKVMLSERKGTDELYA
HHEECCCCCCCCEEE
63.21-
368PhosphorylationRKGTDELYAVKILKK
CCCCCCEEEEEEECC
13.80-
387O-linked_GlycosylationQDDDVECTMVEKRVL
CCCCEEEEEEEEEEE
15.6718295358
408PhosphorylationPFLTQLHSCFQTMDR
CHHHHHHHHHHHHHH
25.81-
412PhosphorylationQLHSCFQTMDRLYFV
HHHHHHHHHHHHHHE
10.78-
500PhosphorylationWDGVTTKTFCGTPDY
CCCCCCCCCCCCCCC
23.2823991683
504PhosphorylationTTKTFCGTPDYIAPE
CCCCCCCCCCCCCCH
17.7327097102
507PhosphorylationTFCGTPDYIAPEIIA
CCCCCCCCCCCHHHC
10.5327097102
515PhosphorylationIAPEIIAYQPYGKSV
CCCHHHCCCCCCCCH
10.3023991683
518PhosphorylationEIIAYQPYGKSVDWW
HHHCCCCCCCCHHHH
22.97-
628PhosphorylationARDKRDTSNFDKEFT
CCCCCCCCCCCHHHH
39.53-
634 (in isoform 2)Phosphorylation-9.33-
635PhosphorylationSNFDKEFTRQPVELT
CCCCHHHHCCCCEEC
29.508327493
641 (in isoform 2)Phosphorylation-7.6628689409
642PhosphorylationTRQPVELTPTDKLFI
HCCCCEECCCCEEEE
15.618327493
644PhosphorylationQPVELTPTDKLFIMN
CCCEECCCCEEEEEE
40.3027097102
654 (in isoform 2)Phosphorylation-55.2927097102
660 (in isoform 2)Phosphorylation-4.5321738781
661PhosphorylationQNEFAGFSYTNPEFV
CCCCCCCCCCCCCCE
30.088749392
662PhosphorylationNEFAGFSYTNPEFVI
CCCCCCCCCCCCCEE
14.31-
664 (in isoform 2)Phosphorylation-26.3527097102

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
16SPhosphorylationKinasePRKCBP68403
GPS
17TPhosphorylationKinasePRKCBP68403
GPS
314TPhosphorylationKinasePRKCBP68403
GPS
324TPhosphorylationKinasePRKCBP68403
GPS
500TPhosphorylationKinasePDPK1O55173
Uniprot
635TPhosphorylationKinasePRKCBP68403
GPS
642TPhosphorylationKinasePRKCBP68403
GPS
661SPhosphorylationKinasePRKCBP68403
GPS
662YPhosphorylationKinaseSYKQ64725
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
500TPhosphorylation

8749392
500TPhosphorylation

8749392
641TPhosphorylation

22673903
642TPhosphorylation

8749392
660SPhosphorylation

22673903
661SPhosphorylation

8749392

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of KPCB_RAT !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HMGB1_RATHmgb1physical
10617144
HOIL1_RATRbck1physical
9514928
H11_RATHist1h1aphysical
11118818
STXB1_RATStxbp1physical
8631738
PEBP1_RATPebp1physical
12551925
CD5_HUMANCD5physical
11123317
CXA1_RATGja1physical
10871288
NMDE2_MOUSEGrin2bphysical
11306676
ANXA7_HUMANANXA7physical
11278415
BCL2_MOUSEBcl2physical
7929424

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of KPCB_RAT

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Crystal structure and allosteric activation of protein kinase CbetaII.";
Leonard T.A., Rozycki B., Saidi L.F., Hummer G., Hurley J.H.;
Cell 144:55-66(2011).
Cited for: X-RAY CRYSTALLOGRAPHY (4.00 ANGSTROMS) OF 1-661 IN COMPLEX WITHCALCIUM IONS, AND PHOSPHORYLATION AT THR-500; THR-642 AND SER-661.
"Characterization of site-specific mutants altered at protein kinase Cbeta 1 isozyme autophosphorylation sites.";
Zhang J., Wang L., Petrin J., Bishop W.R., Bond R.W.;
Proc. Natl. Acad. Sci. U.S.A. 90:6130-6134(1993).
Cited for: PHOSPHORYLATION AT SER-16; THR-17; THR-314; THR-324; THR-635 ANDTHR-642, AND MUTAGENESIS OF 16-SER-THR-17; THR-314; THR-324; THR-635AND THR-642.
"Protein kinase C is regulated in vivo by three functionally distinctphosphorylations.";
Keranen L.M., Dutil E.M., Newton A.C.;
Curr. Biol. 5:1394-1403(1995).
Cited for: PROTEIN SEQUENCE OF 500-520 AND 636-663 (ISOFORM BETA-II), ANDPHOSPHORYLATION AT THR-500; THR-642 AND SER-661.
"Phosphorylation of Thr642 is an early event in the processing ofnewly synthesized protein kinase C beta 1 and is essential for itsactivation.";
Zhang J., Wang L., Schwartz J., Bond R.W., Bishop W.R.;
J. Biol. Chem. 269:19578-19584(1994).
Cited for: PHOSPHORYLATION AT THR-642 (ISOFORM BETA-I), AND MUTAGENESIS OFTHR-635 AND THR-642.

TOP